Skip to content
Industrial Relations, Medical Health Aged Care

New study reveals multi-billion dollar economic benefit of implementing universal reproductive leave in Australia

Health Services Union 3 mins read

New study reveals multi-billion dollar economic benefit of implementing universal reproductive leave in Australia 

 

Giving workers the equivalent of one day of leave a month to care for their reproductive needs would mitigate the economic costs of reproductive health conditions, which are estimated to cost the Australian economy more than $21 billion per year, and improve mental health and workforce retention, according to a new report.

 

Bankwest Curtin Economics Centre’s final report into the Costs and Benefits of Implementing a Universal Reproductive Health Leave Entitlement in Australia, released today, outlines the costs and benefits of a 12-day leave policy. 

 

The report, commissioned by the Health Services Union, the Health and Community Services Union, Aware Super and the Queensland Council of Unions, shows the cost to the economy of not implementing a leave policy, is about $21.3 billion annually in lost productivity from absenteeism and presenteeism. 

 

“This policy will largely benefit women, who represent half of our population, and for most, that comes with menstruation which can bring pain, as well as conditions like endometriosis, IVF, miscarriage, and menopause,” Health Services Union National Senior Assistant Secretary Kate Marshall said. 

 

“By rolling out a universal entitlement of 12 days a year, we will give all workers, particularly women, dignity and agency to be a part of a workforce that doesn’t currently reflect our needs.

 

“This is not sick leave. Work can be extremely difficult when you are dealing with pain or reproductive conditions,” Kate Marshall said.

 

Bankwest Curtin Economics Centre Senior Research Fellow and report lead Dr Silvia Salazar said that the annual net cost of 12 days of reproductive health leave would be $1.7 billion, which is the equivalent of only $140 per year per employed worker. 

 

“The lost productivity from reproductive health conditions costs Australian businesses a massive $21 billion each year,” Dr Salazar said.

 

“Paid reproductive health leave won’t eradicate these conditions, but it will support workers affected by health challenges and bring far greater equity into the workforce, at a fraction of the costs employers are currently experiencing from lost productivity.”

 

Key report facts: 

  • Menstrual pain affects more than half of all working women, while endometriosis impacts 1 in 7, and 74% of women aged 45–55 report menopause symptoms, with 17% requiring extended leave.

  • Miscarriage affects up to 1 in 3 women, and 8% of women aged 25–45 undergo IVF annually.

  • Vasectomies and hysterectomies are also common, particularly in those aged between 35 and 44.

  • 12 days of paid Reproductive Health Leave (RHL) would cost an average of $3.6 billion to implement, but would save $1.88 billion for businesses directly.

  • These implementation costs are small in comparison to the annual $21.3 billion cost to businesses of lost productivity from workers having to manage reproductive health conditions.

  • Of the more than 1,000 workers surveyed, more than nine in 10 living with reproductive health conditions said RHL leave would improve their productivity, mental health, stress levels and workplace loyalty.

  • But 68% of those surveyed said they hadn’t disclosed their condition to their manager.

  • Workers surveyed said they often used sick leave or unpaid time off, with 44% taking unpaid leave when they had symptoms, not out of choice but out from a lack of available leave options.

 

“This report confirms that reproductive health leave is not a luxury, it’s a necessity,” Queensland Council of Unions General Secretary Jacqueline King said. 

 

“Queensland has already led the way, with the Queensland Labor Government introducing ten days’ paid reproductive health leave for state public servants in 2024, thanks to the tireless campaigning of workers and unions.

 

“But unless this becomes a National Employment Standard, too many workers will continue to miss out. That’s why we’re continuing our campaign for reproductive health leave for every worker in Australia.

 

“Reproductive needs are still highly stigmatised, and workers fear discrimination for taking leave for anything relating to their reproductive organs and that shouldn’t be the culture we accept. We want hard-working people to succeed in their careers, but also support their wellbeing by being able to take care of their reproductive health needs,” HSU’s National Secretary Lloyd Williams said. 

 

Media contact: 

Kathleen Ferguson (HSU) - 0421 522 080 

Lucien Wilkinson (Curtin University) - 0401 103 683

Pema Bastin (QCU) 0484 585 446

 

More from this category

  • Medical Health Aged Care, Research Development
  • 11/07/2025
  • 16:28
The Florey

Harnessing mRNA to prevent and slow Alzheimer’s disease

mRNA Victoria funds 2Floreyprojects to prevent and treat Alzheimer’s disease Key points mRNA Victoria has funded 2 Alzheimer’s disease research projects that could position Victoria as a leader in the development of mRNA-based therapies. Dr Abdel Belaidi will develop an mRNA-based system that crosses the blood-brain barrier and aims to slow or even halt disease progression. Dr Rebecca Nisbet will develop an mRNA vaccine that aims to prevent Alzheimer’s disease from developing. Florey researchers working at the cutting edge of dementia research have received funding from mRNA Victoria to develop treatments and a vaccine for Alzheimer’s disease. Since mRNA vaccines…

  • Medical Health Aged Care
  • 11/07/2025
  • 07:05
Royal Australian College of GPs

GPs urge Tasmanian families to get vaccinated against whooping cough and call for free shots to reduce barriers

The Royal Australian College of GPs (RACGP) is urging Tasmanian families to get vaccinated against pertussis, or ‘whooping cough’ and called on all parties and candidates running in the state election to commit to making the vaccination free for all patients. From 1 January 2024 to April 2025, 1238 whooping cough cases were notified in Tasmania, including 10 infants aged under six months. Most hospitalisations and deaths occur in this group, who are not old enough to have received all vaccine doses. More than 21,000 infections were recorded nationwide last year, compared to just 2450 in 2023, and the National…

  • Contains:
  • General News, Medical Health Aged Care
  • 11/07/2025
  • 07:00
La Trobe University

La Trobe researchers awarded $4.5 million in ARC Future Fellowships

LaTrobe University researchers have secured almost $4.5 million in Federal Government funding to further studies into areas such as immune cell development, Australian history and agriculture. Four researchers received an Australian Research Council (ARC) Future Fellowship 2025. The prestigious Future Fellowships support high quality research in areas of national and international benefit, including in national research priorities. Dr Lisa Mielke, from the School of Cancer Medicine, the La Trobe Institute of Molecular Science (LIMS) and the Olivia Newton-John Cancer Research Institute (ONJCRI), received $1.13 million to identify new molecules for future drug and vaccine development to improve gut health in…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.